Calgary biotech moving to Vancouver, going public

A new Calgary-based biotech focused on diabetes and hypertension will go public later this month in a reverse takeover with a local junior mining company ...
Xortx founder Allen Davidoff

A new Calgary-based biotech focused on diabetes and hypertension will go public later this month in a reverse takeover with a local junior mining company and relocate to Vancouver.

Xortx Pharma Corp. – a biotech startup whose management team has ties with Vancouver’s Cardiome Pharma Corp. (TSX:COM) – is focused on treating hypertension, insulin resistance and diabetes-related kidney disease with a reformulated drug – Xorlo – a variation of which has been used to successfully treat gout.

The company hopes to raise $6 million to $9 million through a reverse takeover involving African Queen Mines Ltd. (TSX-V: AQ) in late June or early July. The money is to help pay for clinical trials.

Xortx founder Allen Davidoff said he plans to relocate the company to Vancouver, in part because that is where African Queen is located, although Davidoff also has ties here.

“Vancouver has a wealth of life science professionals, capital market folks who understand the life sciences theme and a biotech research infrastructure that’s very attractive,” Davidoff said.

Davidoff was a senior scientist with Cardiome before he moved to Calgary and founded his own company, Stem Cell Therapeutics Corp. – now Trillium Therapeutics Inc. (TSX: SSS).

Co-founder Alan Moore is also a former Cardiome scientist, as are two other members of the Xortx management team.

Xorlo is a reformulated drug based on the primary chemistry of a drug that is already approved for gout.

One of the things gout has in common with hypertension, insulin resistance and diabetes-related kidney disease is high levels of serum uric acid, Davidoff said. It is believed that Xorlo can be used to lower those levels to treat three types of diseases. However, the company will focus first on hypertension.

nbennett@biv.com

@nbennett_biv

comments powered by Disqus

More from Technology

BC Tech touts Cascadia links ahead of federal government’s skilled foreign workers ...

Association venturing to Seattle to draw more technology talent north

Read Article

SFU Surrey researcher tests tool to help at-risk youth

Mental health treatment aimed at assisting Lower Mainland’s largest youth population

Read Article

BIV on Global BC May 18, 2017: Trudeau at Microsoft summit; Housing ...

Hayley Woodin discusses Trudeau promoting Canadian tech at Microsoft summit. Plus: What are the chances of Canada's housing market going bust?

Read Article

Vancouver biotech Novelogics partners with CDRD to advance cancer treatment

Read Article

Body heat: Young tech workers drive market migration

Vancouver technology companies find employees want to be close to where their peers are – and, increasingly, that is not in a shiny downtown office ...

Read Article

Subscribe to our mailing lists

* indicates required

Newsletters

* You can modify your newsletter subscriptions at the bottom of any newsletter you receive.
×